What does 2025 Hold for Biopharma? Insights and opportunities.
Full article published in: Citeline Each year, Scrip asks over 30 prominent biopharma executives, including our CEO, Liesbeth Ceelen, to gain insights on how funding, M&A, and partnerships are expected to shape the industry in the coming...
BioLizard has been listed as a Trends Gazelle
As a fast-growing company, BioLizard has been recognised as one of the companies to watch in 2025! This recognition is part of a joint initiative by Trends, Change the Game, and Kanaal Z, which closely monitors companies achieving the greatest growth based on value...
BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data
Bio|Verse Navigator can accelerate data exploration and interpretation workflows multifold, reducing time-to-insight for researchers. The application combines advanced BioLizard’s bioinformatics expertise in handling various customer datasets with powerful visual...